Article
Abstract 4350: Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer.
Cancer Research
(2013)
Disciplines
Publication Date
April 15, 2013
DOI
10.1158/1538-7445.AM2013-4350
Citation Information
Tomoki Yamano, Hidenori Nakajima, Satoshi Tsuda, Shuji Kubo, et al.. "Abstract 4350: Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer." Cancer Research Vol. 73 (2013) p. 4350 - 4350 Available at: http://works.bepress.com/dave-hoon/119/